Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
News £17.9m for Advanced Therapy Treatment Centre network to bolster UK clinical trial infrastructure The network includes the Midlands-Wales Advanced Therapy Treatment Centre, jointly delivered by University of Birmingham and University Hospitals Birmingham.
15 February 2023 Efficacy of BCG vaccine in reducing COPD exacerbations funded for £1.8M University of Birmingham researchers have received a £1.8M grant by the NIHR EME Programme investigating BCG vaccine efficacy in reducing COPD exacerbations.
08 February 2023 Leukaemia trial testing vaccine strategies to combat immune suppression The IMPROVE clinical trial is testing whether vaccine timing can help clinically vulnerable people build antibodies
03 February 2023 Immunocompromised patients remain at higher risk of COVID-19 death in hospital Patients had 44% higher risk of death in hospital compared to those with healthy immune system function
16 January 2023 Experimental cancer therapy research continues at Birmingham New and innovative ways to detect and treat cancer being trialled at Birmingham are to receive renewed funding from Cancer Research UK and the NIHR.
08 December 2022 MDS colleagues celebrate receiving MRC clinical fellowships Two University of Birmingham researchers have been awarded prestigious Medical Research Council (MRC) clinical fellowships this year.
01 December 2022 Immune T cell defence is coping with COVID-19 variants of concern – for now Broad T-cell response is currently protective but recognition of seven out of ten T-cell targets mutated in SARS-CoV-2 variants is impaired
14 November 2022 New UK-first trial to screen 20,000 children for type 1 diabetes Blood tests will identify children likely to develop type 1 diabetes, allowing earlier, safer diagnosis